We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2082:TADAWULACWA Power Company Analysis

Data as of 2026-05-24 - not real-time

SAR 184.70

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

ACWA Power trades at SAR 184.7, comfortably above its 20‑day SMA of 176.4 and edging toward the resistance level of 201.8. The 50‑day SMA sits at 172.4, confirming a short‑term upward bias, while the 200‑day SMA of 194.2 signals a longer‑term neutral stance. Technical momentum is bullish, with the MACD line (3.34) above its signal (2.80) and a positive histogram of 0.54. RSI at 57.9 indicates the stock is neither overbought nor oversold, and volume is on an increasing trend, supporting the price advance. Despite these technical strengths, the valuation metrics are starkly misaligned: a trailing P/E of 78.6 versus an industry average of 22, and a DCF‑derived fair value of only SAR 24.4. The implied upside/downside of –21 % underscores that the market price is heavily overvalued.
The company generates SAR 7.47 bn in revenue with modest 2.8 % growth, but its profit margins (gross 48 %, operating 28 %, net 24 %) are offset by a massive debt load of SAR 31.37 bn (debt‑to‑equity ≈ 98). Free cash flow is negative (‑SAR 3.38 bn) despite strong operating cash flow, raising concerns about liquidity and capital allocation. The balance sheet is further strained by a high leverage ratio, while the return on equity of 7 % and ROA of 2.3 % suggest limited efficiency. The utility sector in Saudi Arabia is subject to tight regulatory oversight and geopolitical exposure across the Middle East, Africa and Asia, adding medium‑to‑high geographic risk. The stock’s beta is near zero (≈ 0.12), indicating low market‑wide systematic risk, yet the 30‑day volatility of 50 % points to significant price swings. Given the combination of strong short‑term technicals but severe overvaluation and balance‑sheet weakness, the outlook is cautious.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • bullish MACD and rising volume
  • price near resistance but overvalued
  • neutral trend direction

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • high leverage and negative free cash flow
  • modest revenue growth
  • large valuation gap persists

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • significant overvaluation versus DCF fair value
  • heavy debt burden
  • regulatory and geopolitical exposure

Key Metrics & Analysis

Financial Health

Revenue Growth2.80%
Profit Margin23.70%
P/E Ratio78.6
ROE7.05%
ROA2.30%
Debt/Equity97.72
P/B Ratio4.8
Op. Cash FlowSAR4.1B
Free Cash FlowSAR-3375674112
Industry P/E22.0

Technical Analysis

TrendNeutral
RSI57.9
SupportSAR 163.40
ResistanceSAR 201.80
MA 20SAR 176.41
MA 50SAR 172.36
MA 200SAR 194.24
MACDBullish
VolumeIncreasing
Fear & Greed Index91.61

Valuation

Fair ValueSAR 24.38
Target PriceSAR 145.43
Upside/Downside-21.26%
GradeOvervalued
TypeBlend

Risk Assessment

Beta0.12
Volatility50.25%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.